IP Library Granted Patent US 8,546,307
Granted Patent B2
US 8,546,307 · App. 12/572,877 · Granted Oct 1, 2013

Triple tag sequence and methods of use thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,546,307
App. No.
12/572,877
Granted
Oct 1, 2013
Kind
B2
Abstract

The present disclosure relates to novel triple tag sequences that may comprise a 6× histidine tag, a c-myc tag and a V5 tag. The present disclosure also provides polynucleotides, proteins, vectors and host cells that comprise the triple tag sequence of the present disclosure, including libraries of such polynucleotides, proteins, vectors and host cells. The novel triple tag sequences of the present disclosure may be used in phage display vectors and phage libraries and in methods for detection, screening, capture, purification, quantitation, and/or recovery of proteins of interest to which they are linked. Proteins of interest include antibodies such as single chain antibodies, single chain antibodies, and Fab fragments of antibodies or peptides such as non-antibody peptides.

Claims (5)

1. A method of screening a phagemid library of proteins of interest, wherein the library comprises a plurality of vectors which each comprise a polynucleotide coding for a protein of interest linked to a polynucleotide coding for a triple tag sequence, wherein the triple tag sequence comprises 6X histidine (SEQ ID NO: 1), c-myc (SEQ ID NO: 2) and V5 (SEQ ID NO: 3), said method comprising:

(a.) expressing a plurality of proteins of interest linked to the triple tag sequence from the plurality of vectors;

(b.) screening the proteins of interest linked to the triple tag sequence for binding to a binding partner of the protein of interest; and

(c.) recovering the proteins of interest linked to the triple tag sequence that are bound in step (b.) by capture with an antibody specific for V5, c-myc or 6X histidine,

wherein the triple tag sequence is HHHHHHGAAEQKLISEEDLKAAGKPIPNPLLGLDST (SEQ ID NO: 5), and wherein the protein of interest is a single chain antibody.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 19, 2026
From: XOMA TECHNOLOGY LTD.
To: XOMA (US) LLC
Reel/Frame 073831/0803 →
RELEASE OF SECURITY INTEREST Recorded Dec 23, 2025
From: SILICON VALLEY BANK
To: XOMA TECHNOLOGY LTD.
Reel/Frame 073790/0484 →
SECURITY INTEREST Recorded May 9, 2018
From: XOMA TECHNOLOGY LTD.
To: SILICON VALLEY BANK
Reel/Frame 046115/0459 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2010
From: RONDON, ISAAC; ROELL, MARINA; BEDINGER, DANIEL
To: XOMA TECHNOLOGY LTD.
Reel/Frame 023878/0360 →